KMT2D and male reproductive organ cancer: In the aspect of somatic mutation frequency, patients in the high‐level cluster had a higher frequency of somatic mutations in KMT2D (Figure 4A and Table S2), which has been reported to sustain prostate carcinogenesis and metastasis.44, 45